A New Protein Girdin in Tumor Metastasis
Wang Jing,Fu Li,Gu Feng,Ma Yong-jie
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.2010.13.031
IF: 6.133
2010-01-01
Chinese Medical Journal
Abstract:The phosphatidylinositol 3-kinase/Akt serine/threonine kinase system regulates multiple cellular processes through the phosphorylation of a great number of downstream substrates and has been recognized as an important pathway for signal transduction, and in cancer invasion and metastasis.1 Although it is accepted that Akt promotes the metastasis of human malignant tumors, the mechanisms of Akt function to promote cell migration remains to be elucidated. Girdin, a novel Akt-binding protein, has been designated as a coiled-coil domain containing 88a (Ccdc88a) by the HUGO Gene Nomenclature Committee.2–6 Girdin has been reported to be highly expressed in human malignant tissues such as breast cancer, colon cancer, lung cancer, and uterine cervical carcinomas.7 Girdin was first named as APE and discovered by Japanese researchers in 2005 using full-length mouse Akt as bait in a yeast two-hybrid screen of an embryonic mouse complementary DNA library and 5′- rapid amplification of cDNA ends by PCR.3 Recently, other groups independently identified this novel protein which was also named as HkRP1 or GIV.4,5 Girdin, as a substrate of Akt, also functions as an Akt modulator. It can enhance the phosphorylation of Akt during cell cycle. Akt also mediates the phosphorylation of Girdin to play an essential role in both the remodeling of the actin cytoskeleton and in tumor progression, including migration, invasion, metastasis and angiogenesis. STRUCTURES OF GIRDIN Girdin is a novel protein expressed ubiquitously in mammals. The human Girdin cDNA encodes a large protein of 1870 amino acids with a predicted molecular mass of about 220 kDa.6 At present, the Girdin protein family contains Girdin, Daple, and HkRP3/FLJ00354.8 Girdin and Daple are expressed in virtually all mammalian tissues and found in various cell lines, while HkRP3 is preferentially expressed in the hematopoietic system.6 Girdin, Daple, and HkRP3 share considerable homology at their N terminus to the microtubule-binding domain of the HOOK family of proteins, which have been proposed to link various organelles to microtubules.9 Daple, which possesses 48% identity and 67% similarity overall to Girdin,4 is a newly characterized protein that contains a PDZ binding motif. Daple interacts with Dvl which is a protein involved in regulating the Wnt signaling pathway through this binding motif.10 Overexpression of Daple leads to negative regulation of the Wnt pathway. Wnt signaling pathways are essential in various developmental processes including differentiation, proliferation, cell migration, and cell polarity.4 More recently, data have indicated that Wnt signaling is closely associated with cell polarity in directly promoting the invasiveness and malignant progression of diverse forms of human cancer.11 FLJ00354 shows 36% identity and 58% similarity to Girdin.4 At present, very few studies about HkRP3 have been reported and its function remains unknown. The structure of Girdin can be divided into four different regions based on the sequence of its subunits and subcellular localization; an N-terminal region that seems to facilitate the formation of a dimmer (NT), a central large coiled-coil domain, the halved C-terminal region named CT1 (including an Akt phosphorylation site) and another C-terminal region named CT2. The coiled-coil domain is flanked by the N-terminal (∽253 amino acids) and C-terminal domains (∽495 amino acids). Girdin localizes to the actin filament via its CT2 domain, and it associates with the plasma membrane via its CT1 domain.2 INTERACTION WITH AKT Girdin was shown to be a novel Akt-specific binding protein both in vivo and in vitro.3 By overexpressing Girdin, the basal phosphorylation of Akt was enhanced and Girdin had a higher affinity for nonphosphorylated Akt than for phosphorylated Akt. Furthermore, small interfering RNA-mediated knock-down of Girdin inhibited insulin-stimulated Akt phosphorylation and reduced DNA synthesis.3 PI3K/Akt signaling regulates numerous cellular processes, and has been identified as an important signaling pathway for cancer invasion and metastasis.1,12–15 Our previous study reported that knocking down Akt expression could inhibit glioma cell migration and invasion.16 Moreover, other research groups proved that over-expression of a wild-type of Akt could enhance breast cancer cell invasion in vitro and metastasis in animal models.17 It has been established that Akt preferentially phosphorylates substrates that contain the sequence R-x-R-x-x-S/T.18 The amino acid sequence adjacent to a serine at position 1416 in the CT domain of Girdin conforms to this consensus sequence. As an Akt substrate and an actin binding protein, Girdin is an integral component for increasing cell DNA synthesis, reduction of apoptosis, and may participate in Akt-mediated cancer progression and angiogenesis.2–3,19 INTERACTION WITH G&Agr; PROTEINS Heterotrimeric G proteins mediate signals from a superfamily of heptahelical G protein-coupled receptors (GPCR) to effector units. GPCRs activate the trimeric G proteins, which in turn leads to a variety of downstream responses.20 Le-Niculescu et al4 found that members of the Gαs and Gαi subfamilies of trimeric G proteins are direct targets of Girdin. Ghosh et al21 identified GIV/Girdin as a Gαi3 binding partner, and demonstrated that Gαi3 preferentially localizes to the leading edge and controls the functions of GIV during cell migration in mammalian cells. Their results revealed that cells lacking Gαi3 failed to polarize or migrate. Furthermore, Le-Niculescu et al4 demonstrated the Gα protein- interacting domain is located near to the Akt phosphorylation site in Girdin. Further studies are required to elucidate how Akt and Girdin regulate the function of Gα proteins. REGULATION MOTILITY AND INVASION OF CANCER CELLS It has been reported that Girdin expression could be found in human cancer specimens, including breast invasive ductal carcinomas, and carcinomas of the digestive tract, uterine cervix, lung, and thyroid. High and moderate expression of Girdin was detected in 48% to 75% of these tumors. Such findings indicated that Girdin probably plays a crucial role in tumors.7 Actin is one of the major ingredients in microfilaments of the cytoskeleton which is the basic structure controlling cellular motility by dynamic reorganization. The remodeling of actin cytoskeleton plays a key role in cancer metastasis.22 It is demonstrated that Girdin possess versatile functions in a multitude of cellular processes by the binding proteins which include actin filaments, Akt, heterotrimeric G proteins, and dynamin GTPase. Although the significance of these interactions have not been fully elucidated, Girdin may be involved in signaling from G protein-coupled receptors or membrane trafficking, actin organization and cell migration.7 The integrity and dynamic reorganization of the actin cytoskeleton are essential for cellular morphogenesis and generation of the forces needed for motility. Actin polymerization forms the basis of numerous forms of cell motility. New filaments attach transiently to the surface, subsequently dissociate and become free to polymerize, which is thought to occur at the leading edge of eukaryotic cells and push the membrane forward.22 Girdin, as a novel actin-binding protein, plays a crucial role in the remodeling of the actin cytoskeleton. Enomoto et al2 reported that the Girdin CT1 domain is anchored at the plasma membrane via binding to phosphoinositides, where it subsequently crosslinks actin filaments and anchors cortical actin at the plasma membrane. Since the phosphoinositide binding site is located near the Akt phosphorylation site of the CT1 domain of Girdin, it is indicated that Akt might control the localization of Girdin by regulation of its phosphoinositide binding property. Jiang et al7 demonstrated that the knocking down of Girdin in breast cancer cells led to an increase in the number of cells with rugged cortical actin filaments, and disruption of stress fibers. These observations suggested that Girdin plays a key role in remodeling of peripheral actin filaments and actin dynamics at the peripheral lamellipodia in migrating cells. Furthermore, Girdin siRNA-transfected cells displayed a significant reduction in cell migration and invasion in Boyden chamber assays and Matrigel invasion assays. Therefore, Akt-mediated phosphorylation indicates that Girdin functions not only on the actin stress fibers,2 but also at the leading edge to colocalize newly generated short filaments during cell migration.6 Our previous report demonstrated that phosphorylation of Girdin was significantly decreased after reduction of Akt2 in glioblastoma cells, that led to the impaired migration and invasion of these cancer cells.16 Our results also support the hypothesis that one possible molecular mechanism of Akt2 participating in the migration and invasion in glioblastoma is through the regulation of Girdin phosphorylation. REGULATION OF ANGIOGENESIS It is known that the migration of endothelial cells is a crucial process for vessel sprouting, branching and the formation of networks during angiogenesis. Kitamura et al.19 used human umbilical vein endothelial cells to study the function of Girdin in angiogenesis in vitro, and demonstrated that Akt-mediated phosphorylation of Girdin may promote VEGF-dependent migration of endothelial cells, tube formation and microvessel sprouting in postnatal angiogenesis. In addition, examination in nude mice revealed that Girdin displays a significant role in postnatal microvascular remodeling in the retina and the sprouting of vessels from the aorta. However, the mechanisms of Girdin regulation of angiogenesis have not been fully elucidated.19 FUTURE PROSPECTS Akt has been intensely studied for its role in cancer progression. Accumulating evidence has indicated that the Akt signaling pathway plays an important role in the motility of cancer cells. Therefore, Akt and its downstream substrates have become potential therapeutic targets in malignant tumors. Girdin, as an Akt substrate and an actin-binding protein, may also be involved in a multitude of cellular processes (Figure). Previous reports indicated that Girdin is located at the leading edge of eukaryotic cells, and participates in endocytosis and exocytosis, extention of lamellipodia, and regulation of metastasis. However, the molecular mechanisms of these cellular processes are unclear, and further studies are required to delineate whether the regulation in cancer invasion and migration is related to any of its regulators.Figure.: The possible signaling pathways of Girdin. RTK: receptor tyrosine kinase; GPCR: G protein coupled receptor; PDK1: phosphoinositide-dependent kinase 1.In addition, under which conditions the Akt/Girdin signaling pathway is responsible for VEGF-mediated cancer angiogenesis remains to be elucidated. Collectively, the advance of basic and clinical research on Girdin will represent a novel target for therapeutic interventions in human cancer.